News
Nearly 7,000 luxury units were sold across the top seven cities — Delhi-NCR, Mumbai, Pune, Bengaluru, Kolkata, Hyderabad, and ...
ATGC Biotech Recognised with Innovation Leadership Award 2025 for Transforming Crop Protection through Deep-Tech Innovation ...
NewsBriefs - YZi Labs collaborates with 10X Capital to launch BNB treasury company aiming for US IPO
YZi Labs, linked to former Binance CEO Changpeng 'CZ' Zhao, is supporting 10X Capital to launch a BNB treasury company ...
Indian agritech investments rebound in 2024, with investors eyeing profitability and growth, reaching $411.74 million, ...
WHILE much of the world is fixated on the latest artificial intelligence breakthroughs and billion-dollar tech IPOs, Tanzania ...
India’s purchase of Russian crude is driven by commercial intent rather than any geographical consideration, according to AS ...
The ASX dipped as profit-taking hit the banks, miners surged on China’s steel crackdown, and GemLife soared on debut ...
Unisound AI Technology Co. Ltd. (9678.HK) made its Hong Kong trading debut on Monday, offering investors a new artificial ...
Circle wants a national trust bank. That’s the play. After its stock exploded post-IPO, the company filed a formal request on ...
In an interview with Moneycontrol, Bajaj shares insights into this transformation, the massive market opportunity he sees ...
During a clinical trial, around 83% (10 out of 12) of patients who received a full dose of Zimislecel achieved complete ...
16d
Stockhead on MSNHealth Check: Paradigm makes scenic acquisitive detour, but it’s no strategic shiftOsteoarthritis drug developer Paradigm says its purchase of an oral drug candidate won't distract it from its key phase III .
Some results have been hidden because they may be inaccessible to you
Show inaccessible results